Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypesAmparo García-López, Léonardo Scapozza|Nature Communications|2018Cited by 69
Modified, cyclic dodecapeptide analog of neuropeptide Y is the smallest full agonist at the human Y<sub>2</sub> receptorBeate Rist, Annette G. Beck‐Sickinger, Nikolaus Ingenhoven et al.|FEBS Letters|1996Cited by 42